Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Janet Wei

Showing results (81-90 of 190) with videos related to

Pageof 19
Sort By:
Journal of the American Heart Association|April 10, 2020
Predicted Versus Observed Major Adverse Cardiac Event Risk in Women With Evidence of Ischemia and No Obstructive Coronary Artery Disease: A Report From WISE (Women's Ischemia Syndrome Evaluation)Tara Sedlak, Romana Herscovici, Galen Cook-Wiens, et al.
International Journal of Cardiology|September 3, 2016
Heart failure hospitalization in women with signs and symptoms of ischemia: A report from the women's ischemia syndrome evaluation studyMay Bakir, Michael D Nelson, Erika Jones, et al.
JACC. Cardiovascular Interventions|October 20, 2018
Intracoronary Bolus Injection Versus Intravenous Infusion of Adenosine for Assessment of Coronary Flow Velocity Reserve in Women With Signs and Symptoms of Myocardial Ischemia and No Obstructive Coronary Artery DiseaseAhmed AlBadri, Behzad Sharif, Janet Wei, et al.
Journal of the American College of Cardiology|June 16, 2022
Safety of Provocative Testing With Intracoronary Acetylcholine and Implications for Standard ProtocolsTatsunori Takahashi, Bruce A Samuels, Weijia Li, et al.
American Heart Journal Plus : Cardiology Research and Practice|March 17, 2025
Myocardial biomarkers in coronary microvascular dysfunction: Response to ranolazineKatherine E Hampilos, Anum Asif, Puja K Mehta, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|November 25, 2025
Persistent chest pain trends at 3 years in women with INOCA vs. obstructive CAD: results from the NHLBI-sponsored women's ischemia syndrome evaluation (WISE)Okezi Obrutu, Martha Gulati, Steven Reis, et al.
JACC. Advances|September 26, 2024
Evaluation of Recurrent Takotsubo SyndromePaul Marano, Jenna Maughan, Okezi Obrutu, et al.
Current Atherosclerosis Reports|June 20, 2020
Even "WISE-R?"-an Update on the NHLBI-Sponsored Women's Ischemia Syndrome EvaluationLili Barsky, C Noel Bairey Merz, Janet Wei, et al.
Plos One|September 27, 2021
Coronary endothelial dysfunction appears to be a manifestation of a systemic process: A report from the Women's Ischemia Syndrome Evaluation - Coronary Vascular Dysfunction (WISE-CVD) studySawan Jalnapurkar, Sofy Landes, Janet Wei, et al.
Arxiv|August 16, 2024
Improved Robustness for Deep Learning-based Segmentation of Multi-Center Myocardial Perfusion MRI Datasets Using Data Adaptive Uncertainty-guided Space-time AnalysisDilek M Yalcinkaya, Khalid Youssef, Bobak Heydari, et al.
Pageof 19

Showing results (81-90 of 190) with videos related to

Sort By:
Pageof 19
Journal of the American Heart Association|April 10, 2020
Predicted Versus Observed Major Adverse Cardiac Event Risk in Women With Evidence of Ischemia and No Obstructive Coronary Artery Disease: A Report From WISE (Women's Ischemia Syndrome Evaluation)Tara Sedlak, Romana Herscovici, Galen Cook-Wiens, et al.
International Journal of Cardiology|September 3, 2016
Heart failure hospitalization in women with signs and symptoms of ischemia: A report from the women's ischemia syndrome evaluation studyMay Bakir, Michael D Nelson, Erika Jones, et al.
JACC. Cardiovascular Interventions|October 20, 2018
Intracoronary Bolus Injection Versus Intravenous Infusion of Adenosine for Assessment of Coronary Flow Velocity Reserve in Women With Signs and Symptoms of Myocardial Ischemia and No Obstructive Coronary Artery DiseaseAhmed AlBadri, Behzad Sharif, Janet Wei, et al.
Journal of the American College of Cardiology|June 16, 2022
Safety of Provocative Testing With Intracoronary Acetylcholine and Implications for Standard ProtocolsTatsunori Takahashi, Bruce A Samuels, Weijia Li, et al.
American Heart Journal Plus : Cardiology Research and Practice|March 17, 2025
Myocardial biomarkers in coronary microvascular dysfunction: Response to ranolazineKatherine E Hampilos, Anum Asif, Puja K Mehta, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|November 25, 2025
Persistent chest pain trends at 3 years in women with INOCA vs. obstructive CAD: results from the NHLBI-sponsored women's ischemia syndrome evaluation (WISE)Okezi Obrutu, Martha Gulati, Steven Reis, et al.
JACC. Advances|September 26, 2024
Evaluation of Recurrent Takotsubo SyndromePaul Marano, Jenna Maughan, Okezi Obrutu, et al.
Current Atherosclerosis Reports|June 20, 2020
Even "WISE-R?"-an Update on the NHLBI-Sponsored Women's Ischemia Syndrome EvaluationLili Barsky, C Noel Bairey Merz, Janet Wei, et al.
Plos One|September 27, 2021
Coronary endothelial dysfunction appears to be a manifestation of a systemic process: A report from the Women's Ischemia Syndrome Evaluation - Coronary Vascular Dysfunction (WISE-CVD) studySawan Jalnapurkar, Sofy Landes, Janet Wei, et al.
Arxiv|August 16, 2024
Improved Robustness for Deep Learning-based Segmentation of Multi-Center Myocardial Perfusion MRI Datasets Using Data Adaptive Uncertainty-guided Space-time AnalysisDilek M Yalcinkaya, Khalid Youssef, Bobak Heydari, et al.
Pageof 19